Guru Fundamental Report for TMO

Validea's guru fundamental report indicates Thermo Fisher Scientific Inc. (TMO) scored 50% on its Multi-Factor Investor model, based on Pim van Vliet's strategy, which prioritizes low volatility, strong momentum, and high net payout yields. While TMO, a large-cap medical equipment stock, passed criteria for market cap and standard deviation, it received 'NEUTRAL' ratings for momentum and net payout yield, leading to a 'FAIL' on its final rank within this model. This 50% rating falls significantly short of the 80-90%+ threshold for strong interest, suggesting TMO does not fully align with the quantitative criteria of this specific low-risk, multi-factor strategy.

Analysis

Thermo Fisher Scientific Inc. (TMO) has been evaluated using Validea's Multi-Factor Investor model, which is based on Pim van Vliet's strategy targeting low-volatility stocks with strong momentum and high net payout yields. According to this specific quantitative screen, TMO received a final score of 50% and a 'FAIL' rank, placing it well below the 80% threshold that would indicate strategic interest. While the large-cap medical equipment stock successfully passed the model's criteria for market capitalization and standard deviation, confirming its low-volatility characteristics, it was flagged for underperformance in other key areas. The stock received 'NEUTRAL' ratings for its 'Twelve Minus One Momentum' and 'Net Payout Yield', indicating a lack of significant recent price appreciation and modest capital returns to shareholders. The moderately negative sentiment score of -0.4 reflects this specific model's disapproval, but the low market impact score suggests this is a niche, factor-based view rather than a broad market-moving assessment.

Key Decisions for Investors

• Investors employing conservative, multi-factor strategies should note that TMO does not currently meet the criteria for momentum and net payout yield, despite its attractive low-volatility profile.
• The 'FAIL' rating is specific to a quantitative model and should not be the sole basis for a decision, but it does highlight the stock's current weakness in factor-driven return characteristics.
• Portfolio managers should monitor TMO's price momentum and capital return policies, as any improvement in these metrics would be required for the stock to screen more favorably under similar low-risk, high-yield strategies.